@article{108c296abdcd484ba3c7e7009fb931c6,
title = "Multidrug resistance in Entamoeba histolytica",
abstract = "Drug resistance in protozoon parasites has been emerging in the past decade as an obstacle to their control. Amoebiasis, caused by Entamoeba histolytica, is a worldwide disease that provokes high rates of morbidity and mortality. Reports of failed drug treatment and differences in drug susceptibilities among E. histolytica strains probably herald the development of drug resistance in this parasite. In this review, Esther Orozco and co-workers summarize recent progress on the elucidation of physiological and molecular evidence of multidrug resistance in this parasite.",
author = "E. Orozco and P{\'e}rez, {D. G.} and G{\'o}mez, {M. C.} and P. Ayala",
note = "Funding Information: Acknowledgements We thankR imaG hatalbehf or critical reading of this manuscript. The authors acknowledge John Samuelson for his valuable comments and collaboration on the study of mukldrug resistancei n E. histolytka. This work was supported by an International Research Scholar Award from the Howard Hughes Medlcal Institute and by the International Agency for Atomic Energy Fig. 3. The 5{\textquoteright} end flanking sequences of several structural genes of Entamoeba histolytica. The putative TATA-box consensus sequences as well as the conserved motifs ATTCA or ATCA at the stat-t of transcription are printed in bold capital letters. Nucleotides that do not match the consensus sequences are underlined.",
year = "1995",
doi = "10.1016/0169-4758(95)80067-0",
language = "Ingl{\'e}s",
volume = "11",
pages = "473--475",
journal = "Parasitology Today",
issn = "0169-4758",
number = "12",
}